Q2 2023 G1 Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the G1 Second Quarter Financial Results Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.
I would now like to hand the conference over to the speaker today, Will Roberts. Please go ahead.
Thank you, Janet. Good morning, everyone, and welcome to the G1 conference call to discuss our second quarter 2023 financial results and business update. The press release on these financial results was issued this morning and can be found in the News section of our corporate website, G1therapeutics.com.
On this mornings' call, the team will provide a business overview of the second quarter of 2023, including an update on our clinical programs and our commercial progress in that period with COSELA, which is approved and commercially available to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |